Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.87 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.87 |
| ▸ | LMNA | P02545 | 1/20 | 0.87 |
| ▸ | THRB | P10828 | 1/20 | 0.87 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.87 |
| ▸ | CYP17A1 | P05093 | 3/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.46 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.33 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.30 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cedrol SCHEMBL19922576 | 0.95 | ALOX15 (0.84) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| Cedrol SCHEMBL107489 | 0.93 | ALOX15 (1.00) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| Cedrol SCHEMBL19414169 | 0.93 | ALOX15 (1.00) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| Cedrol SCHEMBL107488 | 0.93 | ALOX15 (1.00) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| Cedrol SCHEMBL1866891 | 0.93 | ALOX15 (1.00) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| Cedrol SCHEMBL6510353 | 0.93 | ALOX15 (1.00) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| Cedrol SCHEMBL18603986 | 0.93 | ALOX15 (1.00) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| Cedrol SCHEMBL16440943 | 0.93 | ALOX15 (1.00) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| Cedrol SCHEMBL873203 | 0.89 | ALOX15 (0.90) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| Cedrol SCHEMBL7638029 | 0.86 | ALOX15 (0.84) | ALOX15ALDH1A1LMNATHRBMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11129778-B2 | Compositions containing microcapsules coated with deposition proteins | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2021-09-28 | — | — | US | disclosed |
| US-20200281826-A1 | COMPOSITIONS CONTAINING MICROCAPSULES COATED WITH DEPOSITION PROTEINS | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2020-09-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11129778-B2 | Compositions containing microcapsules coated with deposition proteins | AUP1, CAPG, TTR | ALOX15 2073/4885ALDH1A1 4839/4885LMNA 1665/4885 |
| US-20200281826-A1 | COMPOSITIONS CONTAINING MICROCAPSULES COATED WITH DEPOSITION PROTEINS | AUP1, CAPG, TTR | ALOX15 2073/4885ALDH1A1 4839/4885LMNA 1665/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.